Author

Phyllis M. Salzman

Observed names: PHYLLIS M. SALZMAN, Phyllis M Salzman, Phyllis Salzman

Observed institutions: Boston University, Children's Hospital of Philadelphia, University of Connecticut, University of Massachusetts Chan Medical School, Georgetown University, University of Rochester Medicine, Yale University, Otsuka (United States), Duke Medical Center, Kyowa Kirin (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States), University of Rochester, UConn Health, University of Pennsylvania

OpenAlex ID: A5114029347

Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder

2017 · Joseph R. Calabrese, Raymond Sanchez, et al. · The Journal of Clinical Psychiatry · 136

Tyrosine hydroxylase: Allosteric activation induced by stimulation of central noradrenergic neurons

1975 · Robert H. Roth, Victor H. Morgenroth, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 87

Noradrenergic neurons: Allosteric activation of hippocampal tyrosine hydroxylase by stimulation of the locus coeruleus

1974 · Robert H. Roth, Phyllis M. Salzman, et al. · Biochemical Pharmacology · 66

Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations?

1992 · Jack Ansell, Valerie Klassen, et al. · Journal of Thoracic and Cardiovascular Surgery · 62

The Efficacy and Safety of Oral Desmopressin in Children With Primary Nocturnal Enuresis

2001 · SETH L. SCHULMAN, ARTHUR STOKES, et al. · The Journal of Urology · 56

Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study

2017 · Christoph U. Correll, Eva Kohegyi, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 41

A Randomized Controlled Trial of Etilevodopa in Patients With Parkinson Disease Who Have Motor Fluctuations

2006 · Karen Blindauer, Ira Shoulson, et al. · Archives of Neurology · 30

The Rilutek ® (riluzole) Global Early Access Programme: An open-label safety evaluation in the treatment of amyotrophic lateral sclerosis

2001 · Catherine Debove, Philippe Zeisser, et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · 23

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease

2008 · William B. White, Phyllis Salzman, et al. · Hypertension · 18

In Vivo Recovery and Survival of Monoclonal-Antibody-Purified Factor VIII Concentrates

1991 · Carol K Kasper, Hugh C Kim, et al. · Thrombosis and Haemostasis · 18

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

2017 · Phyllis Salzman, Arash Raoufinia, et al. · Neuropsychiatric Disease and Treatment · 15

2011 · Ronald E. Wilson, Lauren C. Seeberger, et al. · The Neurologist · 10

Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics

2016 · Timothy Peters-Strickland, Cathy Zhao, et al. · CNS Spectrums · 7

Lack of Immune Response to Mouse IgG in Hemophilia A Patients Treated Chronically with Monoclate®, a Monoclonal Antibody Affinity Purified Factor VIII Preparation

1990 · Hugh M Davis, Susan K Brown, et al. · Thrombosis and Haemostasis · 5

Effect of an Increase in Dose of Istradefylline, an A2A Receptor Antagonist, in Levodopa-Treated Patients with Parkinson’s Disease (1962)

2020 · Nobutaka Hattori, Takanobu Nomura, et al. · Neurology

A Pooled Analysis for Eight Randomized Controlled Trials of Istradefylline, an Adenosine A 2A Receptor Antagonist: Efficacy as Adjunct to Levodopa in Parkinson’s Disease (PD) (P3.8-030)

2019 · Stuart Isaacson, Nobutaka Hattori, et al. · Neurology

Effects of aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by disease severity: a post-hoc analysis of QUALIFY

2016 · Phyllis Salzman

PM417. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning: a post-hoc analysis of QUALIFY, a head-to-head study in schizophrenia

2016 · Phyllis Salzman, Ross A. Baker, et al. · The International Journal of Neuropsychopharmacology

Works count: 18

Citation count: 574

H-index: 11

I10-index: 12